{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T04:57:52Z","timestamp":1784264272280,"version":"3.55.0"},"reference-count":164,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,1]]},"DOI":"10.7759\/cureus.59478","type":"journal-article","created":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T21:45:09Z","timestamp":1714599909000},"source":"Crossref","is-referenced-by-count":12,"title":["Multidisciplinary Management Strategies for Long COVID: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Christian","family":"Prusinski","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johana","family":"Klasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimberly  H","family":"McVeigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadia Z","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga P","family":"Fermo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Kubrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen M","family":"Farr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linus C","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Gerardo-Manrique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F","family":"Bergquist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si M","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Engelberg-Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua M","family":"Hare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith L","family":"March","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold I","family":"Caplan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenchun","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Number of COVID-19 cases reported to WHO. (2024). Accessed. April 1, 2024: https:\/\/data.who.int\/dashboards\/covid19\/cases?n=c."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.26624","article-title":"Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers","volume":"93","author":"Baig AM","year":"2021","unstructured":"Baig AM. Chronic COVID syndrome: need for an appropriate medical terminology for long-COVID and COVID long-haulers. J Med Virol. 2021, 93:2555-6. 10.1002\/jmv.26624","journal-title":"J Med Virol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1016\/j.socscimed.2020.113426","article-title":"How and why patients made long COVID","volume":"268","author":"Callard F","year":"2021","unstructured":"Callard F, Perego E. How and why patients made long COVID. Soc Sci Med. 2021, 268:113426. 10.1016\/j.socscimed.2020.113426","journal-title":"Soc Sci Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-20568-4","article-title":"Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19)","volume":"12","author":"van Kampen JJ","year":"2021","unstructured":"van Kampen JJ, van de Vijver DA, Fraaij PL, et al.. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19). Nat Commun. 2021, 12:267. 10.1038\/s41467-020-20568-4","journal-title":"Nat Commun"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.22717","article-title":"A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection. Illness beyond acute infection and public health implications","volume":"324","author":"Datta SD","year":"2020","unstructured":"Datta SD, Talwar A, Lee JT. A proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection. Illness beyond acute infection and public health implications. JAMA. 2020, 324:2251-2. 10.1001\/jama.2020.22717","journal-title":"JAMA"},{"key":"ref6","article-title":"Post-Acute Coronavirus (COVID-19) Syndrome","author":"Chippa V","year":"2023","unstructured":"Chippa V, Aleem A, Anjum F. Post-Acute Coronavirus (COVID-19) Syndrome. StatPearls [Internet], StatPearls Publishing (FL); 2023."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1473-3099(21)00703-9","article-title":"A clinical case definition of post-COVID-19 condition by a Delphi consensus","volume":"22","author":"Soriano JB","year":"2022","unstructured":"Soriano JB, Murthy S, Marshall JC, Relan P, Diaz JV. A clinical case definition of post-COVID-19 condition by a Delphi consensus. Lancet Infect Dis. 2022, 22:e102-7. 10.1016\/S1473-3099(21)00703-9","journal-title":"Lancet Infect Dis"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.15190\/d.2021.19","article-title":"Post-acute sequelae of COVID-19 and the mental health implications","volume":"9","author":"Walia N","year":"2021","unstructured":"Walia N, Lat JO, Tariq R, et al.. Post-acute sequelae of COVID-19 and the mental health implications. Discoveries (Craiova). 2021, 9:e140. 10.15190\/d.2021.19","journal-title":"Discoveries (Craiova)"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14357","article-title":"Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review","volume":"75","author":"Cabrera Martimbianco AL","year":"2021","unstructured":"Cabrera Martimbianco AL, Pacheco RL, Bagattini \u00c2M, Riera R. Frequency, signs and symptoms, and criteria adopted for long COVID-19: a systematic review. Int J Clin Pract. 2021, 75:e14357. 10.1111\/ijcp.14357","journal-title":"Int J Clin Pract"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.931447","article-title":"Historical Insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID","volume":"27","author":"Stefano GB","year":"2021","unstructured":"Stefano GB. Historical Insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID. Med Sci Monit. 2021, 27:e931447. 10.12659\/MSM.931447","journal-title":"Med Sci Monit"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.15585\/mmwr.mm7036a1","article-title":"Long-term symptoms among adults tested for SARS-CoV-2 - United States, January 2020-April 2021","volume":"70","author":"Wanga V","year":"2021","unstructured":"Wanga V, Chevinsky JR, Dimitrov LV, et al.. Long-term symptoms among adults tested for SARS-CoV-2 - United States, January 2020-April 2021. MMWR Morb Mortal Wkly Rep. 2021, 70:1235-41. 10.15585\/mmwr.mm7036a1","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2022.101762","article-title":"The prevalence and long-term health effects of long COVID among hospitalised and non-hospitalised populations: a systematic review and meta-analysis","volume":"55","author":"O'Mahoney LL","year":"2023","unstructured":"O'Mahoney LL, Routen A, Gillies C, et al.. The prevalence and long-term health effects of long COVID among hospitalised and non-hospitalised populations: a systematic review and meta-analysis. EClinicalMedicine. 2023, 55:101762. 10.1016\/j.eclinm.2022.101762","journal-title":"EClinicalMedicine"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiac136","article-title":"Global prevalence of post-Coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review","volume":"226","author":"Chen C","year":"2022","unstructured":"Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global prevalence of post-Coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022, 226:1593-607. 10.1093\/infdis\/jiac136","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.mehy.2021.110538","article-title":"Persistent SARS-2 infections contribute to long COVID-19","volume":"149","author":"Jacobs JJ","year":"2021","unstructured":"Jacobs JJ. Persistent SARS-2 infections contribute to long COVID-19. Med Hypotheses. 2021, 149:110538. 10.1016\/j.mehy.2021.110538","journal-title":"Med Hypotheses"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-021-01104-y","article-title":"Pathological sequelae of long-haul COVID","volume":"23","author":"Mehandru S","year":"2022","unstructured":"Mehandru S, Merad M. Pathological sequelae of long-haul COVID. Nat Immunol. 2022, 23:194-202. 10.1038\/s41590-021-01104-y","journal-title":"Nat Immunol"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.vaccine.2016.02.063","article-title":"Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection","volume":"34","author":"Ng OW","year":"2016","unstructured":"Ng OW, Chia A, Tan AT, Jadi RS, Leong HN, Bertoletti A, Tan YJ. Memory T cell responses targeting the SARS coronavirus persist up to 11 years post-infection. Vaccine. 2016, 34:2008-14. 10.1016\/j.vaccine.2016.02.063","journal-title":"Vaccine"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1172\/JCI140491","article-title":"Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection","volume":"131","author":"Files JK","year":"2021","unstructured":"Files JK, Boppana S, Perez MD, et al.. Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection. J Clin Invest. 2021, 131:e140491. 10.1172\/JCI140491","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","volume":"185","author":"Su Y","year":"2022","unstructured":"Su Y, Yuan D, Chen DG, et al.. Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022, 185:881-95.E20. 10.1016\/j.cell.2022.01.014","journal-title":"Cell"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.86015","article-title":"Viral persistence, reactivation, and mechanisms of long COVID","volume":"12","author":"Chen B","year":"2023","unstructured":"Chen B, Julg B, Mohandas S, Bradfute SB. Viral persistence, reactivation, and mechanisms of long COVID. Elife. 2023, 12:1-15. 10.7554\/eLife.86015","journal-title":"Elife"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.862522","article-title":"Persistent lung injury and prothrombotic state in long COVID","volume":"13","author":"Xiang M","year":"2022","unstructured":"Xiang M, Jing H, Wang C, Novakovic VA, Shi J. Persistent lung injury and prothrombotic state in long COVID. Front Immunol. 2022, 13:862522. 10.3389\/fimmu.2022.862522","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.02.021","article-title":"Stressful beginnings with long-term consequences","volume":"180","author":"Consiglio CR","year":"2020","unstructured":"Consiglio CR, Brodin P. Stressful beginnings with long-term consequences. Cell. 2020, 180:820-1. 10.1016\/j.cell.2020.02.021","journal-title":"Cell"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.09.034","article-title":"Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C)","volume":"183","author":"Gruber CN","year":"2020","unstructured":"Gruber CN, Patel RS, Trachtman R, et al.. Mapping systemic inflammation and antibody responses in multisystem inflammatory syndrome in children (MIS-C). Cell. 2020, 183:982-95.E14. 10.1016\/j.cell.2020.09.034","journal-title":"Cell"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-022-01810-6","article-title":"Unexplained post-acute infection syndromes","volume":"28","author":"Choutka J","year":"2022","unstructured":"Choutka J, Jansari V, Hornig M, Iwasaki A. Unexplained post-acute infection syndromes. Nat Med. 2022, 28:911-23. 10.1038\/s41591-022-01810-6","journal-title":"Nat Med"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.7861\/clinmed.2020-0896","article-title":"Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies","volume":"21","author":"Dani M","year":"2021","unstructured":"Dani M, Dirksen A, Taraborrelli P, Torocastro M, Panagopoulos D, Sutton R, Lim PB. Autonomic dysfunction in 'long COVID': rationale, physiology and management strategies. Clin Med (Lond). 2021, 21:e63-7. 10.7861\/clinmed.2020-0896","journal-title":"Clin Med (Lond)"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93546-5","article-title":"Clinical characterization of dysautonomia in long COVID-19 patients","volume":"11","author":"Barizien N","year":"2021","unstructured":"Barizien N, Le Guen M, Russel S, Touche P, Huang F, Vall\u00e9e A. Clinical characterization of dysautonomia in long COVID-19 patients. Sci Rep. 2021, 11:14042. 10.1038\/s41598-021-93546-5","journal-title":"Sci Rep"},{"key":"ref26","unstructured":"Long COVID or Post-COVID conditions. (2024). Accessed. April 1, 2024: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/long-term-effects\/index.html."},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100288","article-title":"Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms","volume":"2","author":"Song E","year":"2021","unstructured":"Song E, Bartley CM, Chow RD, et al.. Divergent and self-reactive immune responses in the CNS of COVID-19 patients with neurological symptoms. Cell Rep Med. 2021, 2:100288. 10.1016\/j.xcrm.2021.100288","journal-title":"Cell Rep Med"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.37506\/ijfmt.v14i4.12644","article-title":"Spectrum of respiratory involvement in COVID 19 era: an overview","volume":"14","author":"Jain A","year":"2020","unstructured":"Jain A, Talwar D, Kumar S. Spectrum of respiratory involvement in COVID 19 era: an overview. Indian J Forensic Med Toxicol. 2020, 14:6593-9. 10.37506\/ijfmt.v14i4.12644","journal-title":"Indian J Forensic Med Toxicol"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1093\/ptj\/pzaa129","article-title":"Systematic review of changes and recovery in physical function and fitness after severe acute respiratory syndrome-related Coronavirus infection: implications for COVID-19 rehabilitation","volume":"100","author":"Rooney S","year":"2020","unstructured":"Rooney S, Webster A, Paul L. Systematic review of changes and recovery in physical function and fitness after severe acute respiratory syndrome-related Coronavirus infection: implications for COVID-19 rehabilitation. Phys Ther. 2020, 100:1717-29. 10.1093\/ptj\/pzaa129","journal-title":"Phys Ther"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1177\/14799731211002240","article-title":"Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis","volume":"18","author":"Cares-Marambio K","year":"2021","unstructured":"Cares-Marambio K, Montenegro-Jim\u00e9nez Y, Torres-Castro R, et al.. Prevalence of potential respiratory symptoms in survivors of hospital admission after coronavirus disease 2019 (COVID-19): a systematic review and meta-analysis. Chron Respir Dis. 2021, 18:14799731211002240. 10.1177\/14799731211002240","journal-title":"Chron Respir Dis"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32656-8","article-title":"6-month consequences of COVID-19 in patients discharged from hospital: a cohort study","volume":"397","author":"Huang C","year":"2021","unstructured":"Huang C, Huang L, Wang Y, et al.. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021, 397:220-32. 10.1016\/S0140-6736(20)32656-8","journal-title":"Lancet"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.212170","article-title":"Quantitative chest CT assessment of small airways disease in post-acute SARS-CoV-2 infection","volume":"304","author":"Cho JL","year":"2022","unstructured":"Cho JL, Villacreses R, Nagpal P, et al.. Quantitative chest CT assessment of small airways disease in post-acute SARS-CoV-2 infection. Radiology. 2022, 304:185-92. 10.1148\/radiol.212170","journal-title":"Radiology"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0194-2021","article-title":"Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection","volume":"30","author":"Mylvaganam RJ","year":"2021","unstructured":"Mylvaganam RJ, Bailey JI, Sznajder JI, Sala MA. Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection. Eur Respir Rev. 2021, 30:10.1183\/16000617.0194-2021","journal-title":"Eur Respir Rev"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-021-01359-7","article-title":"Persistent clotting protein pathology in Long COVID\/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin","volume":"20","author":"Pretorius E","year":"2021","unstructured":"Pretorius E, Vlok M, Venter C, Bezuidenhout JA, Laubscher GJ, Steenkamp J, Kell DB. Persistent clotting protein pathology in Long COVID\/Post-Acute Sequelae of COVID-19 (PASC) is accompanied by increased levels of antiplasmin. Cardiovasc Diabetol. 2021, 20:172. 10.1186\/s12933-021-01359-7","journal-title":"Cardiovasc Diabetol"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215314","article-title":"Respiratory follow-up of patients with COVID-19 pneumonia","volume":"75","author":"George PM","year":"2020","unstructured":"George PM, Barratt SL, Condliffe R, et al.. Respiratory follow-up of patients with COVID-19 pneumonia. Thorax. 2020, 75:1009-16. 10.1136\/thoraxjnl-2020-215314","journal-title":"Thorax"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2021.08.010","article-title":"Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing","volume":"161","author":"Singh I","year":"2022","unstructured":"Singh I, Joseph P, Heerdt PM, et al.. Persistent exertional intolerance after COVID-19: insights from invasive cardiopulmonary exercise testing. Chest. 2022, 161:54-63. 10.1016\/j.chest.2021.08.010","journal-title":"Chest"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106401","article-title":"Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation","volume":"182","author":"Maniscalco M","year":"2021","unstructured":"Maniscalco M, Ambrosino P, Fuschillo S, Stufano S, Sanduzzi A, Matera MG, Cazzola M. Bronchodilator reversibility testing in post-COVID-19 patients undergoing pulmonary rehabilitation. Respir Med. 2021, 182:106401. 10.1016\/j.rmed.2021.106401","journal-title":"Respir Med"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00144.2020","article-title":"Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?","volume":"318","author":"Kumar K","year":"2020","unstructured":"Kumar K, Hinks TS, Singanayagam A. Treatment of COVID-19-exacerbated asthma: should systemic corticosteroids be used?. Am J Physiol Lung Cell Mol Physiol. 2020, 318:L1244-7. 10.1152\/ajplung.00144.2020","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1159\/000517255","article-title":"Swiss recommendations for the follow-up and treatment of pulmonary long COVID","volume":"100","author":"Funke-Chambour M","year":"2021","unstructured":"Funke-Chambour M, Bridevaux PO, Clarenbach CF, Soccal PM, Nicod LP, von Garnier C. Swiss recommendations for the follow-up and treatment of pulmonary long COVID. Respiration. 2021, 100:826-41. 10.1159\/000517255","journal-title":"Respiration"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202008-1002OC","article-title":"Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment","volume":"18","author":"Myall KJ","year":"2021","unstructured":"Myall KJ, Mukherjee B, Castanheira AM, et al.. Persistent post-COVID-19 interstitial lung disease. An observational study of corticosteroid treatment. Ann Am Thorac Soc. 2021, 18:799-806. 10.1513\/AnnalsATS.202008-1002OC","journal-title":"Ann Am Thorac Soc"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02930-2021","article-title":"High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial)","volume":"59","author":"Dhooria S","year":"2022","unstructured":"Dhooria S, Chaudhary S, Sehgal IS, et al.. High-dose versus low-dose prednisolone in symptomatic patients with post-COVID-19 diffuse parenchymal lung abnormalities: an open-label, randomised trial (the COLDSTER trial). Eur Respir J. 2022, 59:10.1183\/13993003.02930-2021","journal-title":"Eur Respir J"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.991572","article-title":"Health-related quality of life in persons post-COVID-19 infection in comparison to normative controls and chronic pain patients","volume":"10","author":"Moens M","year":"2022","unstructured":"Moens M, Duarte RV, De Smedt A, et al.. Health-related quality of life in persons post-COVID-19 infection in comparison to normative controls and chronic pain patients. Front Public Health. 2022, 10:991572. 10.3389\/fpubh.2022.991572","journal-title":"Front Public Health"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.3390\/ph14080807","article-title":"Lung fibrosis after COVID-19: treatment prospects","volume":"14","author":"Bazdyrev E","year":"2021","unstructured":"Bazdyrev E, Rusina P, Panova M, Novikov F, Grishagin I, Nebolsin V. Lung fibrosis after COVID-19: treatment prospects. Pharmaceuticals (Basel). 2021, 14:807. 10.3390\/ph14080807","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1002\/rcr2.862","article-title":"Lung transplantation for post-COVID-19 pulmonary fibrosis","volume":"9","author":"Gogia P","year":"2021","unstructured":"Gogia P, Attawar S, Singh V, Bhatnagar T, Sharma S, Batra K, Khare S. Lung transplantation for post-COVID-19 pulmonary fibrosis. Respirol Case Rep. 2021, 9:e0862. 10.1002\/rcr2.862","journal-title":"Respirol Case Rep"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1101\/2021.01.31.21250870","article-title":"Immuno-fibrotic drivers of impaired lung function in post-acute sequelae of SARS-CoV-2 infection (PASC)","author":"Chun HJ","year":"2021","unstructured":"Chun HJ, Coutavas E, Pine A, et al.. Immuno-fibrotic drivers of impaired lung function in post-acute sequelae of SARS-CoV-2 infection (PASC). medRxiv. 2021, 10.1101\/2021.01.31.21250870","journal-title":"medRxiv"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciad072","article-title":"1-year outcomes of lung transplantation for Coronavirus disease 2019-associated end-stage lung disease in the United States","volume":"76","author":"Okumura K","year":"2023","unstructured":"Okumura K, Jyothula S, Kaleekal T, Dhand A. 1-year outcomes of lung transplantation for Coronavirus disease 2019-associated end-stage lung disease in the United States. Clin Infect Dis. 2023, 76:2140-7. 10.1093\/cid\/ciad072","journal-title":"Clin Infect Dis"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.3390\/jpm12010046","article-title":"Evolution of echocardiographic abnormalities identified in previously healthy individuals recovering from COVID-19","volume":"12","author":"Tudoran C","year":"2022","unstructured":"Tudoran C, Tudoran M, Cut TG, et al.. Evolution of echocardiographic abnormalities identified in previously healthy individuals recovering from COVID-19. J Pers Med. 2022, 12:46. 10.3390\/jpm12010046","journal-title":"J Pers Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1002\/ejhf.2347","article-title":"Recovery of cardiac function following COVID-19\u00a0-\u00a0ECHOVID-19: a prospective longitudinal cohort study","volume":"23","author":"Lassen MC","year":"2021","unstructured":"Lassen MC, Skaarup KG, Lind JN, et al.. Recovery of cardiac function following COVID-19\u00a0-\u00a0ECHOVID-19: a prospective longitudinal cohort study. Eur J Heart Fail. 2021, 23:1903-12. 10.1002\/ejhf.2347","journal-title":"Eur J Heart Fail"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofad233","article-title":"Systematic review of the prevalence of long COVID","volume":"10","author":"Woodrow M","year":"2023","unstructured":"Woodrow M, Carey C, Ziauddeen N, et al.. Systematic review of the prevalence of long COVID. Open Forum Infect Dis. 2023, 10:233. 10.1093\/ofid\/ofad233","journal-title":"Open Forum Infect Dis"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.38804","article-title":"Prevalence and correlates of long COVID symptoms among US adults","volume":"5","author":"Perlis RH","year":"2022","unstructured":"Perlis RH, Santillana M, Ognyanova K, et al.. Prevalence and correlates of long COVID symptoms among US adults. JAMA Netw Open. 2022, 5:e2238804. 10.1001\/jamanetworkopen.2022.38804","journal-title":"JAMA Netw Open"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2022.01.014","article-title":"Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis","volume":"28","author":"Alkodaymi MS","year":"2022","unstructured":"Alkodaymi MS, Omrani OA, Fawzy NA, et al.. Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022, 28:657-66. 10.1016\/j.cmi.2022.01.014","journal-title":"Clin Microbiol Infect"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.3390\/brainsci11111456","article-title":"Cardiovascular abnormalities and mental health difficulties result in a reduced quality of life in the post-acute COVID-19 syndrome","volume":"11","author":"Giurgi-Oncu C","year":"2021","unstructured":"Giurgi-Oncu C, Tudoran C, Pop GN, Bredicean C, Pescariu SA, Giurgiuca A, Tudoran M. Cardiovascular abnormalities and mental health difficulties result in a reduced quality of life in the post-acute COVID-19 syndrome. Brain Sci. 2021, 11:1456. 10.3390\/brainsci11111456","journal-title":"Brain Sci"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1016\/j.eclinm.2021.101159","article-title":"Symptom persistence despite improvement in cardiopulmonary health - insights from longitudinal CMR, CPET and lung function testing post-COVID-19","volume":"41","author":"Cassar MP","year":"2021","unstructured":"Cassar MP, Tunnicliffe EM, Petousi N, et al.. Symptom persistence despite improvement in cardiopulmonary health - insights from longitudinal CMR, CPET and lung function testing post-COVID-19. EClinicalMedicine. 2021, 41:101159. 10.1016\/j.eclinm.2021.101159","journal-title":"EClinicalMedicine"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.02.003","article-title":"2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"79","author":"Gluckman TJ","year":"2022","unstructured":"Gluckman TJ, Bhave NM, Allen LA, et al.. 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: myocarditis and other myocardial involvement, post-acute sequelae of SARS-CoV-2 infection, and return to play: a report of the American College of Cardiology Solution Set Oversight Committee. J Am Coll Cardiol. 2022, 79:1717-56. 10.1016\/j.jacc.2022.02.003","journal-title":"J Am Coll Cardiol"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.0950","article-title":"Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China","volume":"5","author":"Shi S","year":"2020","unstructured":"Shi S, Qin M, Shen B, et al.. Association of cardiac injury with mortality in hospitalized patients with COVID-19 in Wuhan, China. JAMA Cardiol. 2020, 5:802-10. 10.1001\/jamacardio.2020.0950","journal-title":"JAMA Cardiol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcad.2020.05.013","article-title":"Special article - acute myocardial injury in patients hospitalized with COVID-19 infection: a review","volume":"63","author":"Bavishi C","year":"2020","unstructured":"Bavishi C, Bonow RO, Trivedi V, Abbott JD, Messerli FH, Bhatt DL. Special article - acute myocardial injury in patients hospitalized with COVID-19 infection: a review. Prog Cardiovasc Dis. 2020, 63:682-9. 10.1016\/j.pcad.2020.05.013","journal-title":"Prog Cardiovasc Dis"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2021.04.011","article-title":"Prospective case-control study of cardiovascular abnormalities 6\u00a0months\u00a0following mild COVID-19 in\u00a0healthcare workers","volume":"14","author":"Joy G","year":"2021","unstructured":"Joy G, Artico J, Kurdi H, et al.. Prospective case-control study of cardiovascular abnormalities 6\u00a0months\u00a0following mild COVID-19 in\u00a0healthcare workers. JACC Cardiovasc Imaging. 2021, 14:2155-66. 10.1016\/j.jcmg.2021.04.011","journal-title":"JACC Cardiovasc Imaging"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.1016\/j.carpath.2020.107300","article-title":"Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations","volume":"50","author":"Halushka MK","year":"2021","unstructured":"Halushka MK, Vander Heide RS. Myocarditis is rare in COVID-19 autopsies: cardiovascular findings across 277 postmortem examinations. Cardiovasc Pathol. 2021, 50:107300. 10.1016\/j.carpath.2020.107300","journal-title":"Cardiovasc Pathol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehab075","article-title":"Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance","volume":"42","author":"Kotecha T","year":"2021","unstructured":"Kotecha T, Knight DS, Razvi Y, et al.. Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance. Eur Heart J. 2021, 42:1866-78. 10.1093\/eurheartj\/ehab075","journal-title":"Eur Heart J"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1002\/pmrj.12744","article-title":"Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of breathing discomfort and respiratory sequelae in patients with post-acute sequelae of SARS-CoV-2 infection (PASC)","volume":"14","author":"Maley JH","year":"2022","unstructured":"Maley JH, Alba GA, Barry JT, et al.. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of breathing discomfort and respiratory sequelae in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R. 2022, 14:77-95. 10.1002\/pmrj.12744","journal-title":"PM R"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2021.05.011","article-title":"Long COVID-19: a primer for cardiovascular health professionals, on behalf of the CCS Rapid Response Team","volume":"37","author":"Paterson I","year":"2021","unstructured":"Paterson I, Ramanathan K, Aurora R, et al.. Long COVID-19: a primer for cardiovascular health professionals, on behalf of the CCS Rapid Response Team. Can J Cardiol. 2021, 37:1260-2. 10.1016\/j.cjca.2021.05.011","journal-title":"Can J Cardiol"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-021-00798-2","article-title":"Long-COVID postural tachycardia syndrome: an American Autonomic Society statement","volume":"31","author":"Raj SR","year":"2021","unstructured":"Raj SR, Arnold AC, Barboi A, et al.. Long-COVID postural tachycardia syndrome: an American Autonomic Society statement. Clin Auton Res. 2021, 31:365-8. 10.1007\/s10286-021-00798-2","journal-title":"Clin Auton Res"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1007\/s12026-021-09185-5","article-title":"Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients","volume":"69","author":"Blitshteyn S","year":"2021","unstructured":"Blitshteyn S, Whitelaw S. Postural orthostatic tachycardia syndrome (POTS) and other autonomic disorders after COVID-19 infection: a case series of 20 patients. Immunol Res. 2021, 69:205-11. 10.1007\/s12026-021-09185-5","journal-title":"Immunol Res"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2021-243585","article-title":"COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine","volume":"14","author":"O'Sullivan JS","year":"2021","unstructured":"O'Sullivan JS, Lyne A, Vaughan CJ. COVID-19-induced postural orthostatic tachycardia syndrome treated with ivabradine. BMJ Case Rep. 2021, 14:e243585. 10.1136\/bcr-2021-243585","journal-title":"BMJ Case Rep"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaccas.2021.01.009","article-title":"Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience","volume":"3","author":"Johansson M","year":"2021","unstructured":"Johansson M, St\u00e5hlberg M, Runold M, et al.. Long-haul post-COVID-19 symptoms presenting as a variant of postural orthostatic tachycardia syndrome: the Swedish experience. JACC Case Rep. 2021, 3:573-80. 10.1016\/j.jaccas.2021.01.009","journal-title":"JACC Case Rep"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.ihj.2020.11.092","article-title":"\u2018Ivabradin\u2019 versus \u2018Carvedilol\u2019 in the management of Post-COVID-19 palpitation with sinus tachycardia","volume":"72","author":"Jadhav K","year":"2020","unstructured":"Jadhav K, Jariwala P. \u2018Ivabradin\u2019 versus \u2018Carvedilol\u2019 in the management of Post-COVID-19 palpitation with sinus tachycardia. Indian Heart J. 2020, 72:S33. 10.1016\/j.ihj.2020.11.092","journal-title":"Indian Heart J"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1007\/s10286-020-00727-9","article-title":"A case report of postural tachycardia syndrome after COVID-19","volume":"30","author":"Miglis MG","year":"2020","unstructured":"Miglis MG, Prieto T, Shaik R, Muppidi S, Sinn DI, Jaradeh S. A case report of postural tachycardia syndrome after COVID-19. Clin Auton Res. 2020, 30:449-51. 10.1007\/s10286-020-00727-9","journal-title":"Clin Auton Res"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2021.1992496","article-title":"What are the recommendations for returning athletes who have experienced long term COVID-19 symptoms?","volume":"53","author":"Lindsay RK","year":"2021","unstructured":"Lindsay RK, Wilson JJ, Trott M, et al.. What are the recommendations for returning athletes who have experienced long term COVID-19 symptoms?. Ann Med. 2021, 53:1935-44. 10.1080\/07853890.2021.1992496","journal-title":"Ann Med"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.04.024","article-title":"Post-COVID-19 syndrome (long haul syndrome): description of a multidisciplinary clinic at Mayo Clinic and characteristics of the initial patient cohort","volume":"96","author":"Vanichkachorn G","year":"2021","unstructured":"Vanichkachorn G, Newcomb R, Cowl CT, et al.. Post-COVID-19 syndrome (long haul syndrome): description of a multidisciplinary clinic at Mayo Clinic and characteristics of the initial patient cohort. Mayo Clin Proc. 2021, 96:1782-91. 10.1016\/j.mayocp.2021.04.024","journal-title":"Mayo Clin Proc"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1111\/head.14464","article-title":"Virtual issue: COVID-19 and headache","volume":"63","author":"Caronna E","year":"2023","unstructured":"Caronna E, Pozo-Rosich P. Virtual issue: COVID-19 and headache. Headache. 2023, 63:183-4. 10.1111\/head.14464","journal-title":"Headache"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1097\/NRL.0b013e318165eb94","article-title":"Phenotype-driven preventive strategies for migraine and other headaches","volume":"15","author":"Wheeler SD","year":"2009","unstructured":"Wheeler SD. Phenotype-driven preventive strategies for migraine and other headaches. Neurologist. 2009, 15:59-70. 10.1097\/NRL.0b013e318165eb94","journal-title":"Neurologist"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1007\/s11910-019-0936-9","article-title":"New daily persistent headache: a diagnostic and therapeutic odyssey","volume":"19","author":"Riddle EJ","year":"2019","unstructured":"Riddle EJ, Smith JH. New daily persistent headache: a diagnostic and therapeutic odyssey. Curr Neurol Neurosci Rep. 2019, 19:21. 10.1007\/s11910-019-0936-9","journal-title":"Curr Neurol Neurosci Rep"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1177\/0333102420965132","article-title":"Daily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence: Lessons from the 1890 Russian\/Asiatic flu","volume":"40","author":"Rozen TD","year":"2020","unstructured":"Rozen TD. Daily persistent headache after a viral illness during a worldwide pandemic may not be a new occurrence: Lessons from the 1890 Russian\/Asiatic flu. Cephalalgia. 2020, 40:1406-9. 10.1177\/0333102420965132","journal-title":"Cephalalgia"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1212\/01.CON.0000418645.32032.32","article-title":"Tension-type headache","volume":"18","author":"Kaniecki RG","year":"2012","unstructured":"Kaniecki RG. Tension-type headache. Continuum (Minneap Minn). 2012, 18:823-34. 10.1212\/01.CON.0000418645.32032.32","journal-title":"Continuum (Minneap Minn)"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"78","author":"Silberstein SD","year":"2012","unstructured":"Silberstein SD, Holland S, Freitag F, Dodick DW, Argoff C, Ashman E. Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society. Neurology. 2012, 78:1337-45. 10.1212\/WNL.0b013e3182535d20","journal-title":"Neurology"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1111\/head.14153","article-title":"The American Headache Society Consensus Statement: update on integrating new migraine treatments into clinical practice","volume":"61","author":"Ailani J","year":"2021","unstructured":"Ailani J, Burch RC, Robbins MS. The American Headache Society Consensus Statement: update on integrating new migraine treatments into clinical practice. Headache. 2021, 61:1021-39. 10.1111\/head.14153","journal-title":"Headache"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.3109\/09638288.2011.610496","article-title":"Pacing as a treatment modality in migraine and tension-type headache","volume":"34","author":"McLean A","year":"2012","unstructured":"McLean A, Coutts K, Becker WJ. Pacing as a treatment modality in migraine and tension-type headache. Disabil Rehabil. 2012, 34:611-8. 10.3109\/09638288.2011.610496","journal-title":"Disabil Rehabil"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1007\/s13365-021-00986-w","article-title":"MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis?","volume":"27","author":"Abrams RM","year":"2021","unstructured":"Abrams RM, Safavi F, Tuhrim S, Navis A, Steinberger J, Shin SC. MRI negative myelopathy post mild SARS-CoV-2 infection: vasculopathy or inflammatory myelitis?. J Neurovirol. 2021, 27:650-5. 10.1007\/s13365-021-00986-w","journal-title":"J Neurovirol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1007\/s10072-021-05471-0","article-title":"Critical illness neuropathy in severe COVID-19: a case series","volume":"42","author":"Bocci T","year":"2021","unstructured":"Bocci T, Campiglio L, Zardoni M, et al.. Critical illness neuropathy in severe COVID-19: a case series. Neurol Sci. 2021, 42:4893-8. 10.1007\/s10072-021-05471-0","journal-title":"Neurol Sci"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001146","article-title":"Peripheral neuropathy evaluations of patients with prolonged long COVID","volume":"9","author":"Oaklander AL","year":"2022","unstructured":"Oaklander AL, Mills AJ, Kelley M, Toran LS, Smith B, Dalakas MC, Nath A. Peripheral neuropathy evaluations of patients with prolonged long COVID. Neurol Neuroimmunol Neuroinflamm. 2022, 9:e1146. 10.1212\/NXI.0000000000001146","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1002\/mus.27458","article-title":"Small fiber neuropathy associated with SARS-CoV-2 infection","volume":"65","author":"Abrams RM","year":"2022","unstructured":"Abrams RM, Simpson DM, Navis A, Jette N, Zhou L, Shin SC. Small fiber neuropathy associated with SARS-CoV-2 infection. Muscle Nerve. 2022, 65:440-3. 10.1002\/mus.27458","journal-title":"Muscle Nerve"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)31525-7","article-title":"Inflammatory olfactory neuropathy in two patients with COVID-19","volume":"396","author":"Kirschenbaum D","year":"2020","unstructured":"Kirschenbaum D, Imbach LL, Ulrich S, et al.. Inflammatory olfactory neuropathy in two patients with COVID-19. Lancet. 2020, 396:166. 10.1016\/S0140-6736(20)31525-7","journal-title":"Lancet"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.17305\/bjbms.2021.6341","article-title":"COVID-19 associated cranial nerve neuropathy: a systematic review","volume":"22","author":"Finsterer J","year":"2022","unstructured":"Finsterer J, Scorza FA, Scorza C, Fiorini A. COVID-19 associated cranial nerve neuropathy: a systematic review. Bosn J Basic Med Sci. 2022, 22:39-45. 10.17305\/bjbms.2021.6341","journal-title":"Bosn J Basic Med Sci"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002639","article-title":"Post-acute sensory neurological sequelae in patients with severe acute respiratory syndrome coronavirus 2 infection: the COVID-PN observational cohort study","volume":"163","author":"Odozor CU","year":"2022","unstructured":"Odozor CU, Kannampallil T, Ben Abdallah A, et al.. Post-acute sensory neurological sequelae in patients with severe acute respiratory syndrome coronavirus 2 infection: the COVID-PN observational cohort study. Pain. 2022, 163:2398-410. 10.1097\/j.pain.0000000000002639","journal-title":"Pain"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinph.2020.06.003","article-title":"Critical illness myopathy as a consequence of COVID-19 infection","volume":"131","author":"Tankisi H","year":"2020","unstructured":"Tankisi H, Tankisi A, Harbo T, Markvardsen LK, Andersen H, Pedersen TH. Critical illness myopathy as a consequence of COVID-19 infection. Clin Neurophysiol. 2020, 131:1931-2. 10.1016\/j.clinph.2020.06.003","journal-title":"Clin Neurophysiol"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-020-0201-1","article-title":"Survivorship after COVID-19 ICU stay","volume":"6","author":"Hosey MM","year":"2020","unstructured":"Hosey MM, Needham DM. Survivorship after COVID-19 ICU stay. Nat Rev Dis Primers. 2020, 6:60. 10.1038\/s41572-020-0201-1","journal-title":"Nat Rev Dis Primers"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)00896-5","article-title":"Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study","volume":"398","author":"Katsoularis I","year":"2021","unstructured":"Katsoularis I, Fonseca-Rodr\u00edguez O, Farrington P, Lindmark K, Fors Connolly AM. Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study. Lancet. 2021, 398:599-607. 10.1016\/S0140-6736(21)00896-5","journal-title":"Lancet"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-06062-x","article-title":"High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study","volume":"46","author":"Helms J","year":"2020","unstructured":"Helms J, Tacquard C, Severac F, et al.. High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study. Intensive Care Med. 2020, 46:1089-98. 10.1007\/s00134-020-06062-x","journal-title":"Intensive Care Med"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1007\/s11239-022-02643-3","article-title":"Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum","volume":"54","author":"Barnes GD","year":"2022","unstructured":"Barnes GD, Burnett A, Allen A, et al.. Thromboembolic prevention and anticoagulant therapy during the COVID-19 pandemic: updated clinical guidance from the anticoagulation forum. J Thromb Thrombolysis. 2022, 54:197-210. 10.1007\/s11239-022-02643-3","journal-title":"J Thromb Thrombolysis"},{"key":"ref90","unstructured":"Final Coronavirus disease (COVID-19) treatment guidelines (February 29, 2024). (2024). Accessed. April 1, 2024: https:\/\/files.covid19treatmentguidelines.nih.gov\/guidelines\/covid19treatmentguidelines.pdf."},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1016\/j.tru.2021.100096","article-title":"Thromboembolic complications during and after hospitalization for COVID-19: incidence, risk factors and thromboprophylaxis","volume":"6","author":"Tholin B","year":"2022","unstructured":"Tholin B, Fiskvik H, Tveita A, et al.. Thromboembolic complications during and after hospitalization for COVID-19: incidence, risk factors and thromboprophylaxis. Thrombosis Update. 2022, 6:100096. 10.1016\/j.tru.2021.100096","journal-title":"Thrombosis Update"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020010529","article-title":"Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry","volume":"137","author":"Giannis D","year":"2021","unstructured":"Giannis D, Allen SL, Tsang J, et al.. Postdischarge thromboembolic outcomes and mortality of hospitalized patients with COVID-19: the CORE-19 registry. Blood. 2021, 137:2838-47. 10.1182\/blood.2020010529","journal-title":"Blood"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003349","article-title":"Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up","volume":"4","author":"Salisbury R","year":"2020","unstructured":"Salisbury R, Iotchkova V, Jaafar S, et al.. Incidence of symptomatic, image-confirmed venous thromboembolism following hospitalization for COVID-19 with 90-day follow-up. Blood Adv. 2020, 4:6230-9. 10.1182\/bloodadvances.2020003349","journal-title":"Blood Adv"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2020007938","article-title":"Postdischarge thrombosis and hemorrhage in patients with COVID-19","volume":"136","author":"Patell R","year":"2020","unstructured":"Patell R, Bogue T, Koshy A, et al.. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. 2020, 136:1342-6. 10.1182\/blood.2020007938","journal-title":"Blood"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2021.0488","article-title":"Incidence of 30-day venous thromboembolism in adults tested for SARS-CoV-2 infection in an integrated health care system in Northern California","volume":"181","author":"Roubinian NH","year":"2021","unstructured":"Roubinian NH, Dusendang JR, Mark DG, Vinson DR, Liu VX, Schmittdiel JA, Pai AP. Incidence of 30-day venous thromboembolism in adults tested for SARS-CoV-2 infection in an integrated health care system in Northern California. JAMA Intern Med. 2021, 181:997-1000. 10.1001\/jamainternmed.2021.0488","journal-title":"JAMA Intern Med"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020003968","article-title":"Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge","volume":"5","author":"von Meijenfeldt FA","year":"2021","unstructured":"von Meijenfeldt FA, Havervall S, Adelmeijer J, et al.. Sustained prothrombotic changes in COVID-19 patients 4 months after hospital discharge. Blood Adv. 2021, 5:756-9. 10.1182\/bloodadvances.2020003968","journal-title":"Blood Adv"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007940","article-title":"American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients","volume":"6","author":"Cuker A","year":"2022","unstructured":"Cuker A, Tseng EK, Sch\u00fcnemann HJ, et al.. American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19: March 2022 update on the use of anticoagulation in critically ill patients. Blood Adv. 2022, 6:4975-82. 10.1182\/bloodadvances.2022007940","journal-title":"Blood Adv"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.05.559","article-title":"Prevention, diagnosis, and treatment of VTE in patients with Coronavirus disease 2019: CHEST Guideline and Expert Panel Report","volume":"158","author":"Moores LK","year":"2020","unstructured":"Moores LK, Tritschler T, Brosnahan S, et al.. Prevention, diagnosis, and treatment of VTE in patients with Coronavirus disease 2019: CHEST Guideline and Expert Panel Report. Chest. 2020, 158:1143-63. 10.1016\/j.chest.2020.05.559","journal-title":"Chest"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.031","article-title":"COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review","volume":"75","author":"Bikdeli B","year":"2020","unstructured":"Bikdeli B, Madhavan MV, Jimenez D, et al.. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review. J Am Coll Cardiol. 2020, 75:2950-73. 10.1016\/j.jacc.2020.04.031","journal-title":"J Am Coll Cardiol"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1080\/17843286.2020.1829252","article-title":"Belgian clinical guidance on anticoagulation management in hospitalised and ambulatory patients with COVID-19","volume":"77","author":"Vanassche T","year":"2022","unstructured":"Vanassche T, Orlando C, Vandenbosch K, et al.. Belgian clinical guidance on anticoagulation management in hospitalised and ambulatory patients with COVID-19. Acta Clin Belg. 2022, 77:280-5. 10.1080\/17843286.2020.1829252","journal-title":"Acta Clin Belg"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(21)02392-8","article-title":"Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial","volume":"399","author":"Ramacciotti E","year":"2022","unstructured":"Ramacciotti E, Barile Agati L, Calderaro D, et al.. Rivaroxaban versus no anticoagulation for post-discharge thromboprophylaxis after hospitalisation for COVID-19 (MICHELLE): an open-label, multicentre, randomised, controlled trial. Lancet. 2022, 399:50-9. 10.1016\/S0140-6736(21)02392-8","journal-title":"Lancet"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1055\/s-0041-1727284","article-title":"Venous thromboembolism in patients discharged after COVID-19 hospitalization","volume":"47","author":"Engelen MM","year":"2021","unstructured":"Engelen MM, Vandenbriele C, Balthazar T, et al.. Venous thromboembolism in patients discharged after COVID-19 hospitalization. Semin Thromb Hemost. 2021, 47:362-71. 10.1055\/s-0041-1727284","journal-title":"Semin Thromb Hemost"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-022-01579-5","article-title":"Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID\/post-acute sequelae of COVID-19 (PASC)","volume":"21","author":"Pretorius E","year":"2022","unstructured":"Pretorius E, Venter C, Laubscher GJ, et al.. Prevalence of symptoms, comorbidities, fibrin amyloid microclots and platelet pathology in individuals with long COVID\/post-acute sequelae of COVID-19 (PASC). Cardiovasc Diabetol. 2022, 21:148. 10.1186\/s12933-022-01579-5","journal-title":"Cardiovasc Diabetol"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-021-01283-z","article-title":"Post-acute COVID-19 syndrome","volume":"27","author":"Nalbandian A","year":"2021","unstructured":"Nalbandian A, Sehgal K, Gupta A, et al.. Post-acute COVID-19 syndrome. Nat Med. 2021, 27:601-15. 10.1038\/s41591-021-01283-z","journal-title":"Nat Med"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-023-08187-3","article-title":"Sleep disturbance severity and correlates in post-acute sequelae of COVID-19 (PASC)","volume":"38","author":"Pena-Orbea C","year":"2023","unstructured":"Pena-Orbea C, Lapin B, Li Y, Englund K, Heinzinger C, Foldvary-Schaefer N, Mehra R. Sleep disturbance severity and correlates in post-acute sequelae of COVID-19 (PASC). J Gen Intern Med. 2023, 38:2015-7. 10.1007\/s11606-023-08187-3","journal-title":"J Gen Intern Med"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1080\/19932820.2023.2182704","article-title":"Management of long-COVID-19 patients with sleep disorders: practical advice to general practitioners","volume":"18","author":"Guezguez F","year":"2023","unstructured":"Guezguez F, Romdhani M, Boutaleb-Joutei A, Chamari K, Ben Saad H. Management of long-COVID-19 patients with sleep disorders: practical advice to general practitioners. Libyan J Med. 2023, 18:2182704. 10.1080\/19932820.2023.2182704","journal-title":"Libyan J Med"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD010753.pub2","article-title":"Antidepressants for insomnia in adults","volume":"5","author":"Everitt H","year":"2018","unstructured":"Everitt H, Baldwin DS, Stuart B, et al.. Antidepressants for insomnia in adults. Cochrane Database Syst Rev. 2018, 5:CD010753. 10.1002\/14651858.CD010753.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2013.12.174","article-title":"Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study","volume":"22","author":"Camargos EF","year":"2014","unstructured":"Camargos EF, Louzada LL, Quintas JL, Naves JO, Louzada FM, N\u00f3brega OT. Trazodone improves sleep parameters in Alzheimer disease patients: a randomized, double-blind, and placebo-controlled study. Am J Geriatr Psychiatry. 2014, 22:1565-74. 10.1016\/j.jagp.2013.12.174","journal-title":"Am J Geriatr Psychiatry"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1016\/S0363-5023(96)80352-2","article-title":"Sensitivity of the Jamar Dynamometer in detecting submaximal grip effort","volume":"21","author":"Ashford RF","year":"1996","unstructured":"Ashford RF, Nagelburg S, Adkins R. Sensitivity of the Jamar Dynamometer in detecting submaximal grip effort. J Hand Surg Am. May. 1996, 21:402-5. 10.1016\/S0363-5023(96)80352-2","journal-title":"J Hand Surg Am. May"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m2912","article-title":"NICE advises against using graded exercise therapy for patients recovering from covid-19","volume":"370","author":"Torjesen I","year":"2020","unstructured":"Torjesen I. NICE advises against using graded exercise therapy for patients recovering from covid-19. BMJ. 2020, 370:m2912. 10.1136\/bmj.m2912","journal-title":"BMJ"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2021.07.004","article-title":"Myalgic encephalomyelitis\/chronic fatigue syndrome: essentials of diagnosis and management","volume":"96","author":"Bateman L","year":"2021","unstructured":"Bateman L, Bested AC, Bonilla HF, et al.. Myalgic encephalomyelitis\/chronic fatigue syndrome: essentials of diagnosis and management. Mayo Clin Proc. 2021, 96:2861-78. 10.1016\/j.mayocp.2021.07.004","journal-title":"Mayo Clin Proc"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.104075","article-title":"Heat and cold sensitivity in multiple sclerosis: a patient-centred perspective on triggers, symptoms, and thermal resilience practices","volume":"67","author":"Christogianni A","year":"2022","unstructured":"Christogianni A, O'Garro J, Bibb R, Filtness A, Filingeri D. Heat and cold sensitivity in multiple sclerosis: a patient-centred perspective on triggers, symptoms, and thermal resilience practices. Mult Scler Relat Disord. 2022, 67:104075. 10.1016\/j.msard.2022.104075","journal-title":"Mult Scler Relat Disord"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1097\/YCO.0000000000000713","article-title":"A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment","volume":"34","author":"Vanderlind WM","year":"2021","unstructured":"Vanderlind WM, Rabinovitz BB, Miao IY, et al.. A systematic review of neuropsychological and psychiatric sequalae of COVID-19: implications for treatment. Curr Opin Psychiatry. 2021, 34:420-33. 10.1097\/YCO.0000000000000713","journal-title":"Curr Opin Psychiatry"},{"key":"ref114","doi-asserted-by":"publisher","DOI":"10.1002\/pmrj.12745","article-title":"Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection (PASC)","volume":"14","author":"Fine JS","year":"2022","unstructured":"Fine JS, Ambrose AF, Didehbani N, et al.. Multi-disciplinary collaborative consensus guidance statement on the assessment and treatment of cognitive symptoms in patients with post-acute sequelae of SARS-CoV-2 infection (PASC). PM R. 2022, 14:96-111. 10.1002\/pmrj.12745","journal-title":"PM R"},{"key":"ref115","doi-asserted-by":"publisher","DOI":"10.1111\/j.1532-5415.2005.53221.x","article-title":"The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment","volume":"53","author":"Nasreddine ZS","year":"2005","unstructured":"Nasreddine ZS, Phillips NA, B\u00e9dirian V, et al.. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005, 53:695-9. 10.1111\/j.1532-5415.2005.53221.x","journal-title":"J Am Geriatr Soc"},{"key":"ref116","doi-asserted-by":"publisher","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein MF","year":"1975","unstructured":"Folstein MF, Folstein SE, McHugh PR. \"Mini-mental state\". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975, 12:189-98. 10.1016\/0022-3956(75)90026-6","journal-title":"J Psychiatr Res"},{"key":"ref117","doi-asserted-by":"publisher","DOI":"10.1016\/s0025-6196(12)61905-3","article-title":"A short test of mental status: description and preliminary results","volume":"62","author":"Kokmen E","year":"1987","unstructured":"Kokmen E, Naessens JM, Offord KP. A short test of mental status: description and preliminary results. Mayo Clin Proc. 1987, 62:281-8. 10.1016\/s0025-6196(12)61905-3","journal-title":"Mayo Clin Proc"},{"key":"ref118","article-title":"Population-based norms for the Mini-Mental State Examination by age and educational level","volume":"269","author":"Crum RM","year":"1993","unstructured":"Crum RM, Anthony JC, Bassett SS, Folstein MF. Population-based norms for the Mini-Mental State Examination by age and educational level. JAMA. 1993, 269:2386-91.","journal-title":"JAMA"},{"key":"ref119","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.1991.00530190071018","article-title":"The short test of mental status. Correlations with standardized psychometric testing","volume":"48","author":"Kokmen E","year":"1991","unstructured":"Kokmen E, Smith GE, Petersen RC, Tangalos E, Ivnik RC. The short test of mental status. Correlations with standardized psychometric testing. Arch Neurol. 1991, 48:725-8. 10.1001\/archneur.1991.00530190071018","journal-title":"Arch Neurol"},{"key":"ref120","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-005-0003-0","article-title":"Neuropsychological assessment","volume":"252","author":"Kapur N","year":"2005","unstructured":"Kapur N. Neuropsychological assessment. J Neurol. 2005, 252:1290-1. 10.1007\/s00415-005-0003-0","journal-title":"J Neurol"},{"key":"ref121","doi-asserted-by":"publisher","DOI":"10.1037\/neu0000876","article-title":"Predictors of cognitive dysfunction one-year post COVID-19","volume":"37","author":"Cavaco S","year":"2023","unstructured":"Cavaco S, Sousa G, Gon\u00e7alves A, et al.. Predictors of cognitive dysfunction one-year post COVID-19. Neuropsychology. 2023, 37:557-67. 10.1037\/neu0000876","journal-title":"Neuropsychology"},{"key":"ref122","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2019.02.011","article-title":"Evidence-based cognitive rehabilitation: systematic review of the literature from 2009 through 2014","volume":"100","author":"Cicerone KD","year":"2019","unstructured":"Cicerone KD, Goldin Y, Ganci K, et al.. Evidence-based cognitive rehabilitation: systematic review of the literature from 2009 through 2014. Arch Phys Med Rehabil. 2019, 100:1515-33. 10.1016\/j.apmr.2019.02.011","journal-title":"Arch Phys Med Rehabil"},{"key":"ref123","doi-asserted-by":"publisher","DOI":"10.1016\/j.apmr.2022.10.001","article-title":"Rehabilitation of neuropsychiatric symptoms in patients with long COVID: position statement","volume":"104","author":"Sacks-Zimmerman A","year":"2023","unstructured":"Sacks-Zimmerman A, Bergquist TF, Farr EM, Cornwell MA, Kanellopoulos D. Rehabilitation of neuropsychiatric symptoms in patients with long COVID: position statement. Arch Phys Med Rehabil. 2023, 104:350-4. 10.1016\/j.apmr.2022.10.001","journal-title":"Arch Phys Med Rehabil"},{"key":"ref124","article-title":"The utility of smart home technology within occupational therapy practice","author":"Walthers KZ","year":"2020","unstructured":"Walthers KZ, Zimmer J. The utility of smart home technology within occupational therapy practice. 2020."},{"key":"ref125","doi-asserted-by":"publisher","DOI":"10.1080\/13651501.2021.1993924","article-title":"Meta-analysis of prevalence: the psychological sequelae among COVID-19 survivors","volume":"26","author":"Khraisat B","year":"2022","unstructured":"Khraisat B, Toubasi A, AlZoubi L, Al-Sayegh T, Mansour A. Meta-analysis of prevalence: the psychological sequelae among COVID-19 survivors. Int J Psychiatry Clin Pract. 2022, 26:234-43. 10.1080\/13651501.2021.1993924","journal-title":"Int J Psychiatry Clin Pract"},{"key":"ref126","doi-asserted-by":"publisher","DOI":"10.1111\/nyas.14506","article-title":"The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis","volume":"1486","author":"Deng J","year":"2021","unstructured":"Deng J, Zhou F, Hou W, et al.. The prevalence of depression, anxiety, and sleep disturbances in COVID-19 patients: a meta-analysis. Ann N Y Acad Sci. 2021, 1486:90-111. 10.1111\/nyas.14506","journal-title":"Ann N Y Acad Sci"},{"key":"ref127","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.0109","article-title":"Posttraumatic stress disorder in patients after severe COVID-19 infection","volume":"78","author":"Janiri D","year":"2021","unstructured":"Janiri D, Carf\u00ec A, Kotzalidis GD, Bernabei R, Landi F, Sani G. Posttraumatic stress disorder in patients after severe COVID-19 infection. JAMA Psychiatry. 2021, 78:567-9. 10.1001\/jamapsychiatry.2021.0109","journal-title":"JAMA Psychiatry"},{"key":"ref128","doi-asserted-by":"publisher","DOI":"10.1007\/s10865-018-9984-x","article-title":"Internet-delivered cognitive behaviour therapy for chronic health conditions: a systematic review and meta-analysis","volume":"42","author":"Mehta S","year":"2019","unstructured":"Mehta S, Peynenburg VA, Hadjistavropoulos HD. Internet-delivered cognitive behaviour therapy for chronic health conditions: a systematic review and meta-analysis. J Behav Med. 2019, 42:169-87. 10.1007\/s10865-018-9984-x","journal-title":"J Behav Med"},{"key":"ref129","doi-asserted-by":"publisher","DOI":"10.1136\/ewjm.175.5.338","article-title":"Cognitive behavioral principles in managing chronic disease","volume":"175","author":"White CA","year":"2001","unstructured":"White CA. Cognitive behavioral principles in managing chronic disease. West J Med. 2001, 175:338-42. 10.1136\/ewjm.175.5.338","journal-title":"West J Med"},{"key":"ref130","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcbs.2021.03.003","article-title":"Single-session acceptance and commitment therapy (ACT) interventions for patients with chronic health conditions: a systematic review and meta-analysis","volume":"20","author":"Dochat C","year":"2021","unstructured":"Dochat C, Wooldridge JS, Herbert MS, Lee MW, Afari N. Single-session acceptance and commitment therapy (ACT) interventions for patients with chronic health conditions: a systematic review and meta-analysis. J Contextual Behav Sci. 2021, 20:52-69. 10.1016\/j.jcbs.2021.03.003","journal-title":"J Contextual Behav Sci"},{"key":"ref131","doi-asserted-by":"publisher","DOI":"10.1016\/j.brat.2021.103995","article-title":"Technology-supported acceptance and commitment therapy for chronic health conditions: a systematic review and meta-analysis","volume":"148","author":"Herbert MS","year":"2022","unstructured":"Herbert MS, Dochat C, Wooldridge JS, et al.. Technology-supported acceptance and commitment therapy for chronic health conditions: a systematic review and meta-analysis. Behav Res Ther. 2022, 148:103995. 10.1016\/j.brat.2021.103995","journal-title":"Behav Res Ther"},{"key":"ref132","doi-asserted-by":"publisher","DOI":"10.1007\/s40473-016-0089-y","article-title":"Physical exercise for treatment of mood disorders: a critical review","volume":"3","author":"Hearing CM","year":"2016","unstructured":"Hearing CM, Chang WC, Szuhany KL, Deckersbach T, Nierenberg AA, Sylvia LG. Physical exercise for treatment of mood disorders: a critical review. Curr Behav Neurosci Rep. 2016, 3:350-9. 10.1007\/s40473-016-0089-y","journal-title":"Curr Behav Neurosci Rep"},{"key":"ref133","doi-asserted-by":"publisher","DOI":"10.1080\/02699931.2016.1168284","article-title":"Acute aerobic exercise helps overcome emotion regulation deficits","volume":"31","author":"Bernstein EE","year":"2017","unstructured":"Bernstein EE, McNally RJ. Acute aerobic exercise helps overcome emotion regulation deficits. Cogn Emot. 2017, 31:834-43. 10.1080\/02699931.2016.1168284","journal-title":"Cogn Emot"},{"key":"ref134","doi-asserted-by":"publisher","DOI":"10.1080\/10401230701844661","article-title":"Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia","volume":"20","author":"Krystal AD","year":"2008","unstructured":"Krystal AD, Thakur M, Roth T. Sleep disturbance in psychiatric disorders: effects on function and quality of life in mood disorders, alcoholism, and schizophrenia. Ann Clin Psychiatry. 2008, 20:39-46. 10.1080\/10401230701844661","journal-title":"Ann Clin Psychiatry"},{"key":"ref135","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.14135","article-title":"Musculoskeletal symptoms and relationship with laboratory findings in patients with COVID-19","volume":"75","author":"Batur EB","year":"2021","unstructured":"Batur EB, Korez MK, Gezer IA, Levendoglu F, Ural O. Musculoskeletal symptoms and relationship with laboratory findings in patients with COVID-19. Int J Clin Pract. 2021, 75:e14135. 10.1111\/ijcp.14135","journal-title":"Int J Clin Pract"},{"key":"ref136","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-021-06001-1","article-title":"Long COVID from rheumatology perspective - a narrative review","volume":"41","author":"Sapkota HR","year":"2022","unstructured":"Sapkota HR, Nune A. Long COVID from rheumatology perspective - a narrative review. Clin Rheumatol. 2022, 41:337-48. 10.1007\/s10067-021-06001-1","journal-title":"Clin Rheumatol"},{"key":"ref137","doi-asserted-by":"publisher","DOI":"10.2340\/16501977-2805","article-title":"Effect of neuromuscular electrical stimulation on the recovery of people with COVID-19 admitted to the intensive care unit: a narrative review","volume":"53","author":"Burgess LC","year":"2021","unstructured":"Burgess LC, Venugopalan L, Badger J, et al.. Effect of neuromuscular electrical stimulation on the recovery of people with COVID-19 admitted to the intensive care unit: a narrative review. J Rehabil Med. 2021, 53:jrm00164. 10.2340\/16501977-2805","journal-title":"J Rehabil Med"},{"key":"ref138","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2020-047632","article-title":"Long COVID and the role of physical activity: a qualitative study","volume":"11","author":"Humphreys H","year":"2021","unstructured":"Humphreys H, Kilby L, Kudiersky N, Copeland R. Long COVID and the role of physical activity: a qualitative study. BMJ Open. 2021, 11:e047632. 10.1136\/bmjopen-2020-047632","journal-title":"BMJ Open"},{"key":"ref139","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.0565","article-title":"Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening","volume":"6","author":"Martinez MW","year":"2021","unstructured":"Martinez MW, Tucker AM, Bloom OJ, et al.. Prevalence of inflammatory heart disease among professional athletes with prior COVID-19 infection who received systematic return-to-play cardiac screening. JAMA Cardiol. 2021, 6:745-52. 10.1001\/jamacardio.2021.0565","journal-title":"JAMA Cardiol"},{"key":"ref140","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10173782","article-title":"Long COVID: distinction between organ damage and deconditioning","volume":"10","author":"Kersten J","year":"2021","unstructured":"Kersten J, Baumhardt M, Hartveg P, et al.. Long COVID: distinction between organ damage and deconditioning. J Clin Med. 2021, 10:3782. 10.3390\/jcm10173782","journal-title":"J Clin Med"},{"key":"ref141","doi-asserted-by":"publisher","DOI":"10.1111\/ene.15435","article-title":"Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: evidence of skeletal muscle histopathology","volume":"29","author":"Hejb\u00f8l EK","year":"2022","unstructured":"Hejb\u00f8l EK, Harbo T, Agergaard J, et al.. Myopathy as a cause of fatigue in long-term post-COVID-19 symptoms: evidence of skeletal muscle histopathology. Eur J Neurol. 2022, 29:2832-41. 10.1111\/ene.15435","journal-title":"Eur J Neurol"},{"key":"ref142","doi-asserted-by":"publisher","DOI":"10.1089\/acu.2021.0090","article-title":"The role of acupuncture for long COVID: mechanisms and models","volume":"34","author":"Williams JE","year":"2022","unstructured":"Williams JE, Moramarco J. The role of acupuncture for long COVID: mechanisms and models. Med Acupunct. 2022, 34:159-66. 10.1089\/acu.2021.0090","journal-title":"Med Acupunct"},{"key":"ref143","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.22130","article-title":"Reflections of a COVID-19 long hauler","volume":"324","author":"Siegelman JN","year":"2020","unstructured":"Siegelman JN. Reflections of a COVID-19 long hauler. JAMA. 2020, 324:2031-2. 10.1001\/jama.2020.22130","journal-title":"JAMA"},{"key":"ref144","doi-asserted-by":"publisher","DOI":"10.1016\/j.msard.2022.103742","article-title":"Aerobic exercise increases irisin serum levels and improves depression and fatigue in patients with relapsing remitting multiple sclerosis: a randomized controlled trial","volume":"61","author":"Bilek F","year":"2022","unstructured":"Bilek F, Cetisli-Korkmaz N, Ercan Z, Deniz G, Demir CF. Aerobic exercise increases irisin serum levels and improves depression and fatigue in patients with relapsing remitting multiple sclerosis: a randomized controlled trial. Mult Scler Relat Disord. 2022, 61:103742. 10.1016\/j.msard.2022.103742","journal-title":"Mult Scler Relat Disord"},{"key":"ref145","doi-asserted-by":"publisher","DOI":"10.1016\/j.medj.2022.04.001","article-title":"Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection","volume":"3","author":"Natarajan A","year":"2022","unstructured":"Natarajan A, Zlitni S, Brooks EF, et al.. Gastrointestinal symptoms and fecal shedding of SARS-CoV-2 RNA suggest prolonged gastrointestinal infection. Med. 2022, 3:371-387.e9. 10.1016\/j.medj.2022.04.001","journal-title":"Med"},{"key":"ref146","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(22)00126-6","article-title":"Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study","volume":"10","author":"Huang L","year":"2022","unstructured":"Huang L, Li X, Gu X, et al.. Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study. Lancet Respir Med. 2022, 10:863-76. 10.1016\/S2213-2600(22)00126-6","journal-title":"Lancet Respir Med"},{"key":"ref147","doi-asserted-by":"publisher","DOI":"10.1016\/S2468-1253(21)00076-5","article-title":"Gastrointestinal sequelae 90 days after discharge for COVID-19","volume":"6","author":"Weng J","year":"2021","unstructured":"Weng J, Li Y, Li J, et al.. Gastrointestinal sequelae 90 days after discharge for COVID-19. Lancet Gastroenterol Hepatol. 2021, 6:344-6. 10.1016\/S2468-1253(21)00076-5","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref148","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.14251","article-title":"Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID-19","volume":"34","author":"Blackett JW","year":"2022","unstructured":"Blackett JW, Li J, Jodorkovsky D, Freedberg DE. Prevalence and risk factors for gastrointestinal symptoms after recovery from COVID-19. Neurogastroenterol Motil. 2022, 34:e14251. 10.1111\/nmo.14251","journal-title":"Neurogastroenterol Motil"},{"key":"ref149","doi-asserted-by":"publisher","DOI":"10.1002\/jgh3.12811","article-title":"Symptomatology and microbiology of the gastrointestinal tract in post-COVID conditions","volume":"6","author":"Norouzi Masir M","year":"2022","unstructured":"Norouzi Masir M, Shirvaliloo M. Symptomatology and microbiology of the gastrointestinal tract in post-COVID conditions. JGH Open. 2022, 6:667-76. 10.1002\/jgh3.12811","journal-title":"JGH Open"},{"key":"ref150","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.804644","article-title":"Diagnostic, prognostic, and therapeutic roles of gut microbiota in COVID-19: a comprehensive systematic review","volume":"12","author":"Farsi Y","year":"2022","unstructured":"Farsi Y, Tahvildari A, Arbabi M, et al.. Diagnostic, prognostic, and therapeutic roles of gut microbiota in COVID-19: a comprehensive systematic review. Front Cell Infect Microbiol. 2022, 12:804644. 10.3389\/fcimb.2022.804644","journal-title":"Front Cell Infect Microbiol"},{"key":"ref151","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2021-325989","article-title":"Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome","volume":"71","author":"Liu Q","year":"2022","unstructured":"Liu Q, Mak JW, Su Q, et al.. Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome. Gut. 2022, 71:544-52. 10.1136\/gutjnl-2021-325989","journal-title":"Gut"},{"key":"ref152","doi-asserted-by":"publisher","DOI":"10.3390\/medicines8090047","article-title":"A randomized controlled trial of the efficacy of systemic enzymes and probiotics in the resolution of post-COVID fatigue","volume":"8","author":"Rathi A","year":"2021","unstructured":"Rathi A, Jadhav SB, Shah N. A randomized controlled trial of the efficacy of systemic enzymes and probiotics in the resolution of post-COVID fatigue. Medicines (Basel). 2021, 8:47. 10.3390\/medicines8090047","journal-title":"Medicines (Basel)"},{"key":"ref153","doi-asserted-by":"publisher","DOI":"10.1016\/j.xkme.2020.11.008","article-title":"The prevalence of acute kidney injury in patients hospitalized with COVID-19 infection: a systematic review and meta-analysis","volume":"3","author":"Silver SA","year":"2021","unstructured":"Silver SA, Beaubien-Souligny W, Shah PS, et al.. The prevalence of acute kidney injury in patients hospitalized with COVID-19 infection: a systematic review and meta-analysis. Kidney Med. 2021, 3:83-98.e1. 10.1016\/j.xkme.2020.11.008","journal-title":"Kidney Med"},{"key":"ref154","doi-asserted-by":"publisher","DOI":"10.1038\/s41581-021-00487-3","article-title":"Long COVID and kidney disease","volume":"17","author":"Yende S","year":"2021","unstructured":"Yende S, Parikh CR. Long COVID and kidney disease. Nat Rev Nephrol. 2021, 17:792-3. 10.1038\/s41581-021-00487-3","journal-title":"Nat Rev Nephrol"},{"key":"ref155","doi-asserted-by":"publisher","DOI":"10.1093\/ckj\/sfab003","article-title":"Pathology of COVID-19-associated acute kidney injury","volume":"14","author":"Sharma P","year":"2021","unstructured":"Sharma P, Ng JH, Bijol V, Jhaveri KD, Wanchoo R. Pathology of COVID-19-associated acute kidney injury. Clin Kidney J. 2021, 14:i30-9. 10.1093\/ckj\/sfab003","journal-title":"Clin Kidney J"},{"key":"ref156","doi-asserted-by":"publisher","DOI":"10.1001\/jamahealthforum.2020.1463","article-title":"Delayed care with harmful health consequences-reported experiences from national surveys during Coronavirus disease 2019","volume":"1","author":"Findling MG","year":"2020","unstructured":"Findling MG, Blendon RJ, Benson JM. Delayed care with harmful health consequences-reported experiences from national surveys during Coronavirus disease 2019. JAMA Health Forum. 2020, 1:e201463. 10.1001\/jamahealthforum.2020.1463","journal-title":"JAMA Health Forum"},{"key":"ref157","doi-asserted-by":"publisher","DOI":"10.1002\/sctm.20-0191","article-title":"The vascular nature of lung-resident mesenchymal stem cells","volume":"10","author":"Steens J","year":"2021","unstructured":"Steens J, Klar L, Hansel C, et al.. The vascular nature of lung-resident mesenchymal stem cells. Stem Cells Transl Med. 2021, 10:128-43. 10.1002\/sctm.20-0191","journal-title":"Stem Cells Transl Med"},{"key":"ref158","article-title":"Mesenchymal stem cells: characteristics and clinical applications","volume":"44","author":"Bobis S","year":"2006","unstructured":"Bobis S, Jarocha D, Majka M. Mesenchymal stem cells: characteristics and clinical applications. Folia Histochem Cytobiol. 2006, 44:215-30.","journal-title":"Folia Histochem Cytobiol"},{"key":"ref159","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222212421","article-title":"Immunomodulation and regenerative capacity of MSCs for long-COVID","volume":"22","author":"Loke XY","year":"2021","unstructured":"Loke XY, Imran SA, Tye GJ, Wan Kamarul Zaman WS, Nordin F. Immunomodulation and regenerative capacity of MSCs for long-COVID. Int J Mol Sci. 2021, 22:12421. 10.3390\/ijms222212421","journal-title":"Int J Mol Sci"},{"key":"ref160","unstructured":"Support for rehabilitation. self-management after COVID-19 related illness. (2024). Accessed: April 1, 2024: https:\/\/cdn.who.int\/media\/docs\/default-source\/ageing\/support-for-rehabilitation-self-management-after-covid-19-relate...."},{"key":"ref161","doi-asserted-by":"publisher","DOI":"10.5662\/wjm.v12.i4.235","article-title":"Rehabilitation in long COVID-19: A mini-review","volume":"12","author":"Swarnakar R","year":"2022","unstructured":"Swarnakar R, Yadav SL. Rehabilitation in long COVID-19: A mini-review. World J Methodol. 2022, 12:235-45. 10.5662\/wjm.v12.i4.235","journal-title":"World J Methodol"},{"key":"ref162","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph19095185","article-title":"Rehabilitation interventions for post-acute COVID-19 syndrome: a systematic review","volume":"19","author":"Fugazzaro S","year":"2022","unstructured":"Fugazzaro S, Contri A, Esseroukh O, et al.. Rehabilitation interventions for post-acute COVID-19 syndrome: a systematic review. Int J Environ Res Public Health. 2022, 19:5185. 10.3390\/ijerph19095185","journal-title":"Int J Environ Res Public Health"},{"key":"ref163","doi-asserted-by":"publisher","DOI":"10.1101\/2022.11.23.22282673","article-title":"SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual","author":"Lustig G","year":"2022","unstructured":"Lustig G, Ganga Y, Rodel H, et al.. SARS-CoV-2 evolves increased infection elicited cell death and fusion in an immunosuppressed individual. medRxiv. 2022, 10.1101\/2022.11.23.22282673","journal-title":"medRxiv"},{"key":"ref164","doi-asserted-by":"publisher","DOI":"10.1136\/bmjmed-2022-000385","article-title":"Effect of covid-19 vaccination on long covid: systematic review","volume":"2","author":"Byambasuren O","year":"2023","unstructured":"Byambasuren O, Stehlik P, Clark J, Alcorn K, Glasziou P. Effect of covid-19 vaccination on long covid: systematic review. BMJ Med. 2023, 2:e000385. 10.1136\/bmjmed-2022-000385","journal-title":"BMJ Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/233994-multidisciplinary-management-strategies-for-long-covid-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T21:45:20Z","timestamp":1714599920000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/233994-multidisciplinary-management-strategies-for-long-covid-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,1]]},"references-count":164,"URL":"https:\/\/doi.org\/10.7759\/cureus.59478","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,1]]}}}